Zobrazeno 1 - 10
of 32
pro vyhledávání: '"T. Romanet"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Néphrologie & Thérapeutique. 13:370-371
Introduction L’etude FIND-CKD a valide l’interet d’une cible de ferritinemie (F), entre 400 et 600 ng/mL, dans la prise en charge de l’anemie du patient insuffisant renal chronique non dialyse (IRC-ND). L’objectif de notre travail a ete d
Autor:
Gerard Murphy, Azemi A. Barama, Sophie Fornairon, P. Vialtel, Marco Castagneto, D. Del Castillo, Paul Keown, Franco Citterio, T. Romanet, Greg Knoll, G. Boschiero, D. Uehlinger, N. Muirhead, Ferenc Perner, Tufveson, P. Szenohradszky, Robert Balshaw, David Ludwin, E. Ancona, J. P. Wauters, Paolo Rigotti, Lyse Beauregard-Zollinger, F. Ortega, Hans Prestele, G. Ancona, D. Casadei, Edward H. Cole, Lars Bäckman, José M. Tabernero, Horvath, C. Pouteil-Noble
Publikováno v:
American Journal of Transplantation. 2:157-166
Increasing information suggests that absorption profiling may be superior to trough level monitoring for optimal concentration control of cyclosporine microemulsion (Neoral) therapy, and that CsA exposure early post-transplant may correlate significa
Autor:
T. Romanet, Ferenc Perner, Lyse Beauregard-Zollinger, J. P. Wauters, D. Del Castillo, Hans Prestele, Lars Bäckman, Norman Muirhead, Edward H. Cole, Gerard Murphy, Robert Balshaw, Paul Keown, Franco Citterio, Sophie Fornairon
Publikováno v:
American Journal of Transplantation. 2:148-156
Recent data suggest that optimal cyclosporine (CsA) exposure early post-transplant significantly reduces the risk of acute graft rejection. They indicate that trough level monitoring is inadequate for precise concentration-controlled therapy, and sug
Publikováno v:
Pharmacy worldscience : PWS. 29(1)
Objective: Assessment of a pharmacist-run anaemia educational programme for patients with chr-onic renal insufficiency. Setting: Nephrology Department, Grenoble Hospital, France Method: A 12-week prospective study, using a before–after intervention
Publikováno v:
Nephrologie. 25(3)
Cases of dysgeusia or ageusia have been reported in patients treated with angiotensin II receptor antagonist such as losartan (5 cases), valsartan (1 case), eprosartan (1 case). This is the first case-report of ageusia following candesartan. A 46-yea
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 49:e40
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 49:e108
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression
Autor:
G, Mourad, V, Garrigue, J P, Squifflet, T, Besse, F, Berthoux, E, Alamartine, D, Durand, L, Rostaing, P, Lang, C, Baron, D, Glotz, C, Antoine, P, Vialtel, T, Romanet, Y, Lebranchu, A, Al Najjar, C, Hiesse, L, Potaux, P, Merville, J L, Touraine, N, Lefrancois, M, Kessler, E, Renoult, C, Pouteil-Noble, R, Cahen, C, Legendre, J, Bedrossian, P, Le Pogamp, J, Rivalan, M, Olmer, R, Purgus, F, Mignon, B, Viron, B, Charpentier
Publikováno v:
Transplantation. 72(6)
The aim of this study was to compare the efficacy and safety of induction treatment with antithymocyte globulins (ATG) followed by tacrolimus therapy with immediate tacrolimus therapy in renal transplant recipients.This 12-month, open, prospective st
Publikováno v:
In vivo (Athens, Greece). 13(4)
Only few studies have tried to identify parameters at the time of diagnosis or during treatment that can assist the clinician in predicting the response to Cisplatin, 5-Fluorouracil +/- Folinic acid therapy in patients with head and neck squamous cel